The insider sales are routine in size and pattern (CEO exercising options and selling a portion for cash). No bearish signal is warranted. Monitor for any upcoming 8-K or earnings release that could provide context, but the cluster alone does not justify a trade.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 10 $219.58entry
- T+1 · 2mo ago −0.60%α −1.45% · $218.27
- T+5 · 2mo ago +4.03%α +4.52% · $228.42
- T+20 · 6w ago +3.26%α +1.13% · $226.73
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ResMed's CEO and a director sold a combined ~$1.34M in shares over a week, with the CEO's sale following a derivative exercise. While the dollar amount is trivial relative to the $31.9B market cap (0.004%), the cluster involves the Chairman/CEO and a director, and the CEO's sale was an open-market disposition after a cashless exercise. The cluster is notable but not material enough to drive a bearish call on its own.
Key Financial Metrics
Key Facts
- CEO Michael J. Farrell sold 4,991 shares at $222.44 for ~$1.11M on 2026-09-08, following a derivative exercise of the same number of shares.
- Director Peter C. Farrell sold 970 shares at $234.73 for ~$228K on 2026-09-02.
- Total cluster value is ~$1.34M, representing ~0.004% of ResMed's $31.9B market cap, well below the 0.1% materiality threshold.
- The CEO's sale was an open-market transaction (code S) after a non-cash derivative exercise (code M), a common pattern for tax withholding or diversification.
Financial Impact
Total insider sales of ~$1.34M, or 0.004% of market cap, immaterial in absolute and relative terms.
Risk Factors
- Insider sales, while small, could precede a broader sell-off if other insiders follow suit.
- The CEO's sale after an option exercise may be misinterpreted by the market as a negative signal, creating short-term noise.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RMD-1789038065968 |
Track record
19 reports on RMD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $238.19 +1.74% settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Viewing Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers